hormone testing for men
EMA CHMP recommends approval of linagliptin for type 2 diabetes
Boehringer Ingelheim and Eli Lilly and Company today received a positive opinion from the European Medicines Agency’s (EMA) medicinal committee recommending approval of linagliptin, 5 mg, film-coated tablets (to be marketed under the trade name Trajenta® in Europe) for the treatment of adults with type 2 diabetes.
SalivaTesting.com – Bioidentical Hormones & Hormone Tests

Comments are closed.